Drug profile · INN
goserelin
ZOLADEX
goserelin (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Drug details — goserelin
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 0
- Programs
- 24
- Data quality
- 0.84
Quick answer
goserelin (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is goserelin?
goserelin (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for goserelin?
ZOLADEX is a marketed brand name for goserelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of goserelin?
goserelin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.